Controlling the rhythm of the heart is also tough and risky, as messing with heart rhythm can easily lead to big problems
Patients who transitioned from injectable semaglutide or tirzepatide to once-daily oral orforglipron maintained approximately 7580% of their original weight loss
Appetite suppression deepens, heart-rate effects become more visible, and gut symptoms can return after each increase
Monitor LFTs (Liver Function Tests) and Hemoglobin regularly
Novo and Lilly will sell their treatments to Medicare currently with list prices around $1,000 a month at reduced prices of around $250 a month, and in exchange, plans will eventually be required to cover the drugs for weight loss for high-risk patients
Liu lng v thi gian b sung cn ph hp vi tui tc, gii tnh, tnh trng sc khe, mc ch s dng v cc loi thuc ang dng